Lee KD - Search Results

1

A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention.

Chen J, Liu H, Jehng T, Li Y, Chen Z, Lee KD, Shen HT, Jones L, Huang XF, Chen SY. Chen J, et al. Among authors: lee kd. Cancers (Basel). 2019 Dec 1;11(12):1909. doi: 10.3390/cancers11121909. Cancers (Basel). 2019. PMID: 31805690 Free PMC article.

2

Radiotherapy Is Associated with an Accelerated Risk of Ischemic Stroke in Oral Cavity Cancer Survivors after Primary Surgery.

Kuan FC, Lee KD, Huang SF, Chen PT, Huang CE, Wang TY, Chen MC. Kuan FC, et al. Among authors: lee kd. Cancers (Basel). 2020 Mar 6;12(3):616. doi: 10.3390/cancers12030616. Cancers (Basel). 2020. PMID: 32155918 Free PMC article.

3

Virtual Screening and In Vitro Evaluation of PD-1 Dimer Stabilizers for Uncoupling PD-1/PD-L1 Interaction from Natural Products.

Lung J, Hung MS, Lin YC, Hung CH, Chen CC, Lee KD, Tsai YH. Lung J, et al. Among authors: lee kd. Molecules. 2020 Nov 13;25(22):5293. doi: 10.3390/molecules25225293. Molecules. 2020. PMID: 33202823 Free PMC article.

4

The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.

Chen MF, Chen PT, Chen WC, Lu MS, Lin PY, Lee KD. Chen MF, et al. Among authors: lee kd. Oncotarget. 2016 Feb 16;7(7):7913-24. doi: 10.18632/oncotarget.6861. Oncotarget. 2016. PMID: 26761210 Free PMC article.

5

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.

Chen JS, Hsu C, Chiang NJ, Tsai CS, Tsou HH, Huang SF, Bai LY, Chang IC, Shiah HS, Ho CL, Yen CJ, Lee KD, Chiu CF, Rau KM, Yu MS, Yang Y, Hsieh RK, Chang JY, Shan YS, Chao Y, Chen LT; Taiwan Cooperative Oncology Group. Chen JS, et al. Among authors: lee kd. Ann Oncol. 2015 May;26(5):943-949. doi: 10.1093/annonc/mdv035. Epub 2015 Jan 28. Ann Oncol. 2015. PMID: 25632066 Free article. Clinical Trial.

6

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression.

Fan YC, Lee KD, Tsai YC. Fan YC, et al. Among authors: lee kd. Biomedicines. 2020 Dec 13;8(12):602. doi: 10.3390/biomedicines8120602. Biomedicines. 2020. PMID: 33322099 Free PMC article.

7

Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma.

Shao YY, Lin ZZ, Hsu C, Lee KD, Hsiao CH, Lu YS, Huang CC, Shen YC, Hsu CH, Cheng AL. Shao YY, et al. Among authors: lee kd. Oncology. 2012;82(1):59-66. doi: 10.1159/000336126. Epub 2012 Feb 4. Oncology. 2012. PMID: 22310088 Clinical Trial.

8

Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance.

Chen CC, Chen WC, Wang WH, Lu CH, Lin PY, Lee KD, Chen MF. Chen CC, et al. Among authors: lee kd. Head Neck. 2011 Aug;33(8):1132-43. doi: 10.1002/hed.21586. Epub 2011 Jan 31. Head Neck. 2011. PMID: 21284050

9

Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model.

Fan YC, Chen WY, Lee KD, Tsai YC. Fan YC, et al. Among authors: lee kd. Biology (Basel). 2020 Mar 31;9(4):67. doi: 10.3390/biology9040067. Biology (Basel). 2020. PMID: 32244522 Free PMC article.

10

Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells.

Lee KD, Pai MY, Hsu CC, Chen CC, Chen YL, Chu PY, Lee CH, Chen LT, Chang JY, Huang TH, Hsiao SH, Leu YW. Lee KD, et al. Among authors: lee ch. Biochem Biophys Res Commun. 2012 Jun 15;422(4):578-85. doi: 10.1016/j.bbrc.2012.05.029. Epub 2012 May 14. Biochem Biophys Res Commun. 2012. PMID: 22595458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page